Our organisation:

Pirbright Research Campus

The Pirbright Campus in Surrey is home to The Pirbright Institute and provides a unique centre of national strategic importance with highly specialised facilities and capabilities that contribute to ensuring the preparedness of the UK in relation to viral animal disease. Research at the campus also contributes to human health and wellbeing by understanding certain zoonotic viruses in their farm animal hosts.

Research carried out at the campus provides the capability to control, contain and eliminate viral diseases of livestock, which contributes to safeguarding UK national security.

The campus is the hub of many international research networks and partnerships. It provides diagnostic services, expert analysis and advice nationally and internationally.

Innovation and training

The campus brings together innovative researchers, together with companies working on the same challenges, to enable commercial partnerships that contribute to the development of new vaccines and diagnostics.

It also provides essential training programmes in a unique training environment that contribute to providing highly skilled people for UK bioscience businesses and overseas trainees who then work more effectively to combat viral diseases in their native countries.

Investments

Major developments are underway at the Pirbright Campus. Development phase 1 will deliver new cutting-edge containment laboratory facilities following a £100M+ investment.

In 2011, the Government awarded BBSRC £80M to invest in Pirbright for development phase 2. With an additional £20M from BBSRC's own budget this will allow a £100M+ second phase of development to further enhance this national capability.

Phase 1

Already well underway is the construction of a state-of-the-art containment level 4 laboratory complex due to be handed over to the Institute in early 2014. This will house up to 150 scientists and support staff undertaking research on highly contagious viruses such as foot-and-mouth disease virus, swine fever and highly pathogenic avian influenza viruses.

Phase 2

Currently in design, this second stage of development will include new containment level 2 laboratories. Due for completion in late 2015, these laboratories will accommodate 90 scientists working on viruses that do not require high containment. A new Biological Resources Facility for in-vivo work at various levels of containment is in the planning and is scheduled for completion in 2018

The campus will be an unrivalled and strategically important national and international capability for research and partnerships on major viral diseases of livestock.


Images

These images are protected by copyright law and may be used with acknowledgement.